文献速递骨肿瘤关节外科

膝关节周围近关节骨肉瘤保关节切除后的肿瘤学与功能结局如何?

What are the Oncologic and Functional Outcomes After Joint Salvage Resections for Juxtaarticular Osteosarcoma About the Knee?
PubMed 文献 · Clin Orthop Relat Res · 2017-04-19

2004至2013年治疗117例膝关节周围骨肉瘤患者,43例(38%)接受保关节手术,41例(95%)纳入研究,平均随访4.4年(范围3-11年)。5年总生存率82%(95%CI,104-128个月),5年无局部复发生存率91%(95%CI,115-133个月)。MSTS评分中位数28分(范围22-30分),肿瘤累及骨骺与否在生存率、局部复发和MSTS评分上无差异。

要点

  • 5年总生存率82%,5年无局部复发生存率91%,仅3例局部复发。
  • MSTS评分中位数28分(范围22-30分),肿瘤是否累及骨骺在生存率、局部复发和MSTS评分上无差异。
  • 10例(24%)需额外手术,13例(31%)检出残留骨骺骨坏死。

核心结论

  • 作者认为,在经选择的膝关节周围近关节骨肉瘤患者中,保关节是可行的。
  • 对化疗反应良好的患者是此方法的最佳候选者。

研究设计与样本

  • 回顾性分析2004年至2013年治疗的117例膝关节周围近关节骨肉瘤患者,其中43例(38%)接受保关节手术,41例(95%)纳入研究,2例(5%)在3年前失访。
  • 平均随访4.4年(范围3-11年)。
  • 采用Kaplan-Meier法估算总生存率和无局部复发生存率,采用骨与软组织肿瘤学会(MSTS)-93评分系统评估肢体功能状态。
  • 比较肿瘤累及骨骺组(n=28)与未累及骨骺组(n=13)的肿瘤学与功能结局;并比较不同辅助治疗(微波消融n=11、冷冻消融n=12、导航辅助截骨n=5)患者的结局。

主要发现

  • 5年总Kaplan-Meier生存率为82%(95%CI,104-128个月)。
  • 5年无局部复发Kaplan-Meier生存率为91%(95%CI,115-133个月)。
  • 3例患者出现局部复发,但无1例发生在残留骨骺内或附近。
  • MSTS评分为22至30分,中位数28分。
  • 肿瘤未侵犯骨骺组与侵犯骨骺组在生存率、局部复发或MSTS评分上无差异。

关键数值与推荐

  • 保关节手术的一般选择标准:对化疗反应良好、无病理性骨折或肿瘤突入关节、无全骨骺溶骨性病变、无大肿块、无明显神经血管侵犯。
  • 肿瘤学结局指标:5年总生存率82%(95%CI,104-128个月),5年无局部复发生存率91%(95%CI,115-133个月)。
  • 功能结局指标:MSTS评分范围22-30分,中位数28分。

临床怎么用

  • 作者认为,在经选择的膝关节周围近关节骨肉瘤患者中可保关节,对化疗反应良好者是最佳候选。
  • 未来研究可能探索微波消融和冷冻消融辅助技术的作用,尤其是肿瘤侵犯骨骺时,以及导航是否有助于切除。

局限性

  • 本研究为回顾性研究,证据等级为IV级,治疗性研究。
  • 本研究为先前研究的随访,当前研究增加了9例患者,并对先前报告中的患者增加了平均19个月的额外随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Joint salvage surgery for patients with juxtaarticular osteosarcoma remains challenging, especially when the tumor invades the epiphysis. Because patients are surviving longer with current chemotherapy regimens, it is advantageous to retain native joints if possible, especially in young patients. However, the results using joint-preserving tumor resections in this context have not been well characterized. QUESTIONS/PURPOSES: (1) What are the functional outcomes after limb salvage surgery at a minimum of 3 years? (2) What are the oncologic outcomes? (3) Is joint salvage surgery for epiphyseal tumors associated with an increased risk of local recurrence compared with metaphyseal tumors not invading the epiphysis? (4) What are the complications associated with joint salvage surgery? METHODS: Between 2004 and 2013, we treated 117 patients with juxtaarticular osteosarcoma; of those, 43 (38%) were treated with joint salvage surgery, and 41 (95%) of the 43 patients are included in our study. The other two (5%) were lost to followup before 3 years (mean, 4.4 years; range, 3-11 years,). During the period in question, we generally performed joint salvage surgery in these patients when they had a favorable response to chemotherapy, did not have a pathologic fracture or extrusion of the tumor into the joint, and did not have a whole-epiphyseal osteolytic lesion, a large mass, or obvious neurovascular involvement. This report is a followup of an earlier study; the current study includes an additional nine patients, and additional followup of a mean of 19 months for the patients included in the earlier report. We ascertained overall survival and survival free from local recurrence which was estimated using the Kaplan-Meier method, functional status of the limb which was evaluated using the Musculoskeletal Tumor Society (MSTS)-93 scoring system, and recorded reconstructive complications including infection, fracture, skin necrosis, and nonunion. We compared oncologic and functional outcomes between patients with (n = 28) and without tumor extension to epiphysis (n =13). We also compared oncologic and functional outcomes among patients with different adjuvant treatments including microwave ablation (n = 11), cryoablation (n = 12), and navigation-assisted osteotomy (n = 5). Complications were tallied using records from our institutional database. RESULTS: The overall Kaplan-Mayer survival rate was 82% (95% CI, 104-128 months) at 5 years. The overall Kaplan-Meier survivorship from local recurrence was 91% at 5 years (95% CI, 115-133 months). Three patients had a local recurrence, but none had local recurrence in or close to the remaining epiphysis. The MSTS scores ranged from 22 to 30 points, with a median of 28. There were no differences in survival rate, local recurrence, or MSTS scores between patients with a tumor that did not invade the epiphysis and those in whom the tumor did invade the epiphysis. There were differences in MSTS scores among patients with epiphyseal tumor extension in which different adjuvant techniques, including microwave ablation, cryoablation, and navigation-assisted osteotomy, were used. Additional surgical procedures were recorded for 10 patients (24%). Osteonecrosis of the residual epiphysis was detected 13 patients (31%). CONCLUSIONS: Our findings suggest it is possible to salvage joints in selected patients with juxtaarticular osteosarcoma around the knee. The patients who have a favorable response to chemotherapy are the best candidates for this approach. Future studies might explore the role of adjuvant techniques of microwave ablation and cryoablation, particularly when the tumor invades the epiphysis, and whether resections can be facilitated with navigation. LEVEL OF EVIDENCE: Level IV, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Li J, Wang Z, Ji C, et al. What are the Oncologic and Functional Outcomes After Joint Salvage Resections for Juxtaarticular Osteosarcoma About the Knee? Clin Orthop Relat Res. 2017. PMID: 28425055. doi:10.1007/s11999-017-5356-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。